These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
245 related items for PubMed ID: 19491715
1. Myocardial viability in chronic ischemic heart disease: comparison of delayed-enhancement magnetic resonance imaging with 99mTc-sestamibi and 18F-fluorodeoxyglucose single-photon emission computed tomography. Liu Q, Zhao S, Yan C, Lu M, Jiang S, Zhang Y, Li S, Liu Y, Yang M, He Z. Nucl Med Commun; 2009 Aug; 30(8):610-6. PubMed ID: 19491715 [Abstract] [Full Text] [Related]
2. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging and comparison with single-photon emission computed tomography. Wang YN, Jin ZY, Zhang ZH, Kong LY, Chen LB, Zhou L, Sun HY, Zhang H, Miao Q. Chin Med Sci J; 2006 Dec; 21(4):239-44. PubMed ID: 17249199 [Abstract] [Full Text] [Related]
3. [Assessing myocardial viability in chronic myocardial infarct with 18F-fluoro-D-glucose positron emission tomography and 99mTc-MIBI SPECT]. Schneider CA, Voth E, Theissen P, Wienhard K, Wagner R, Baer FM, Sechtem U, Schicha H. Z Kardiol; 1994 Feb; 83(2):124-31. PubMed ID: 8165842 [Abstract] [Full Text] [Related]
4. [Identification of viable myocardium delayed enhancement magnetic resonance imaging and 99Tcm-sestamibi or 18F-fluorodeoxyglucose single photon emission computed tomography]. Zhao SH, Yan CW, Yang MF, Lu MJ, Jiang SL, Li SG, Zhang Y, Liu Q, Liu YQ, He ZX. Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Dec; 34(12):1072-6. PubMed ID: 17274892 [Abstract] [Full Text] [Related]
5. Electrocardiographic-gated dual-isotope simultaneous acquisition SPECT using 18F-FDG and 99mTc-sestamibi to assess myocardial viability and function in a single study. Matsunari I, Kanayama S, Yoneyama T, Matsudaira M, Nakajima K, Taki J, Nekolla SG, Tonami N, Hisada K. Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):195-202. PubMed ID: 15449050 [Abstract] [Full Text] [Related]
6. Evaluation of myocardial viability in asymptomatic patients early after infarction with perfusion/metabolism single-photon-emission computed tomographic imaging and dobutamine echocardiography. Dangas G, Machac J, Goldman ME, Sharma SK, Shao JH, Cohen AM, Meraj P, Feldman D, Ambrose JA. Coron Artery Dis; 2000 Jul; 11(5):409-14. PubMed ID: 10895407 [Abstract] [Full Text] [Related]
8. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease. vom Dahl J, Altehoefer C, Sheehan FH, Buechin P, Schulz G, Schwarz ER, Koch KC, Uebis R, Messmer BJ, Buell U, Hanrath P. J Nucl Med; 1997 May; 38(5):742-8. PubMed ID: 9170439 [Abstract] [Full Text] [Related]
9. Comparison of 99mTc-sestamibi-18F-fluorodeoxyglucose dual isotope simultaneous acquisition and rest-stress 99mTc-sestamibi single photon emission computed tomography for the assessment of myocardial viability. De Boer J, Slart RH, Blanksma PK, Willemsen AT, Jager PL, Paans AM, Vaalburg W, Piers DA. Nucl Med Commun; 2003 Mar; 24(3):251-7. PubMed ID: 12612465 [Abstract] [Full Text] [Related]
10. [Evaluation of myocardial viability with contrast-enhanced magnetic resonance imaging--comparison of the late enhancement technique with positronemission tomography]. Hunold P, Brandt-Mainz K, Freudenberg L, Vogt FM, Neumann T, Knipp S, Barkhausen J. Rofo; 2002 Jul; 174(7):867-73. PubMed ID: 12101477 [Abstract] [Full Text] [Related]
11. Increased uptake of iodine-123-BMIPP in chronic ischemic heart disease: comparison with fluorine-18-FDG SPECT. Sloof GW, Visser FC, Bax JJ, van Lingen A, Eersels J, Knapp FF, Teule GJ. J Nucl Med; 1998 Feb; 39(2):255-60. PubMed ID: 9476931 [Abstract] [Full Text] [Related]
12. Comparison of contrast-enhanced MRI with (18)F-FDG PET/201Tl SPECT in dysfunctional myocardium: relation to early functional outcome after surgical revascularization in chronic ischemic heart disease. Wu YW, Tadamura E, Yamamuro M, Kanao S, Marui A, Tanabara K, Komeda M, Togashi K. J Nucl Med; 2007 Jul; 48(7):1096-103. PubMed ID: 17607039 [Abstract] [Full Text] [Related]
13. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability: comparison with fluorine-18-FDG PET. Altehoefer C, vom Dahl J, Biedermann M, Uebis R, Beilin I, Sheehan F, Hanrath P, Buell U. J Nucl Med; 1994 Apr; 35(4):569-74. PubMed ID: 8151377 [Abstract] [Full Text] [Related]
14. Assessment of reversible myocardial dysfunction in chronic ischaemic heart disease: comparison of contrast-enhanced cardiovascular magnetic resonance and a combined positron emission tomography-single photon emission computed tomography imaging protocol. Kühl HP, Lipke CS, Krombach GA, Katoh M, Battenberg TF, Nowak B, Heussen N, Buecker A, Schaefer WM. Eur Heart J; 2006 Apr; 27(7):846-53. PubMed ID: 16434414 [Abstract] [Full Text] [Related]
17. Functional evaluation of myocardial viability by 99mTc tetrofosmin gated SPECT--a quantitative comparison with 18F fluorodeoxyglucose positron emission CT (18F FDG PET). Kuwabara Y, Watanabe S, Nakaya J, Fujiwara M, Hasegawa R, Matsuno K, Kuroda T, Mikami Y, Fujii K, Himi T, Masuda Y. Ann Nucl Med; 1999 Jun; 13(3):135-40. PubMed ID: 10435372 [Abstract] [Full Text] [Related]
18. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose. Dilsizian V, Arrighi JA, Diodati JG, Quyyumi AA, Alavi K, Bacharach SL, Marin-Neto JA, Katsiyiannis PT, Bonow RO. Circulation; 1994 Feb; 89(2):578-87. PubMed ID: 8313546 [Abstract] [Full Text] [Related]
19. Evaluation of the clinical value of combination of 99mTc-MIBI myocardial SPECT and 18F-FDG PET in assessing myocardial viability. Zhang X, Liu X, Shi R, Wu Q, Gao R, Liu Y, Hu S, Guo S, Xie F, Li Y. Radiat Med; 1999 Feb; 17(3):205-10. PubMed ID: 10440109 [Abstract] [Full Text] [Related]
20. Agreement and disagreement between contrast-enhanced magnetic resonance imaging and nuclear imaging for assessment of myocardial viability. Roes SD, Kaandorp TA, Marsan NA, Westenberg JJ, Dibbets-Schneider P, Stokkel MP, Lamb HJ, van der Wall EE, de Roos A, Bax JJ. Eur J Nucl Med Mol Imaging; 2009 Apr; 36(4):594-601. PubMed ID: 19050879 [Abstract] [Full Text] [Related] Page: [Next] [New Search]